Screener
Theravance Biopharma TBPH Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's net margin?
- Theravance Biopharma (TBPH) reported net margin of 104.3% in Q1 2026.
- How has Theravance Biopharma's net margin changed year-over-year?
- Theravance Biopharma's net margin increased by 216.7% year-over-year, from -89.4% to 104.3%.
- What is the long-term trend for Theravance Biopharma's net margin?
- Over 5 years (2020 to 2025), Theravance Biopharma's net margin has grown at a -23.9% compound annual growth rate (CAGR), from -386.9% to 98.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Theravance Biopharma's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude